NO166037C - ANALOGY PROCEDURE FOR THE PREPARATION OF NEW THERAPEUTIC ACTIVE NAFTYRIDINE INGREDIENTS. - Google Patents

ANALOGY PROCEDURE FOR THE PREPARATION OF NEW THERAPEUTIC ACTIVE NAFTYRIDINE INGREDIENTS.

Info

Publication number
NO166037C
NO166037C NO875012A NO875012A NO166037C NO 166037 C NO166037 C NO 166037C NO 875012 A NO875012 A NO 875012A NO 875012 A NO875012 A NO 875012A NO 166037 C NO166037 C NO 166037C
Authority
NO
Norway
Prior art keywords
alkyl
pyrrolidinyl
substituted
piperidyl
piperazinyl
Prior art date
Application number
NO875012A
Other languages
Norwegian (no)
Other versions
NO875012L (en
NO166037B (en
NO875012D0 (en
Inventor
Jean-Dominique Bourzat
Marc Capet
Claude Cotrel
Richard Labaudiniere
Philippe Pitchen
Gerard Roussel
Original Assignee
Rhone Poulenc Sante
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Sante filed Critical Rhone Poulenc Sante
Publication of NO875012D0 publication Critical patent/NO875012D0/en
Publication of NO875012L publication Critical patent/NO875012L/en
Publication of NO166037B publication Critical patent/NO166037B/en
Publication of NO166037C publication Critical patent/NO166037C/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02Muscle relaxants, e.g. for tetanus or cramps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D497/00Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D497/02Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D497/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrrole Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Rolls And Other Rotary Bodies (AREA)
  • Polyoxymethylene Polymers And Polymers With Carbon-To-Carbon Bonds (AREA)

Abstract

Derivatives of formula (I), in which A forms with the pyrrole ring an isoindoline, 6,7-dihydro-5H-pyrrolo[3,4-b]pyrazine, 2,3,6,7- tetrahydro-5H-oxathiinno[1,4][2,3C]pyrrole or 2,3,6,7-tetrahydro-5H- dithiinno[1,4][2,3C]pyrrole nucleus and Het = naphthyridinyl, pyridyl or quinolyl which are unsubstituted or substituted by a halogen, alkyl (1-4 C), alkoxy (1-4 C), alkylthio (1-4 C) or CF3, and R = alkenyl (3- 10 C) with a straight or branched chain or alkyl which is unsubstituted or substituted by alkoxy, alkylthio, cycloalkyl (3-6 C), NH2, alkylamino, dialkylamino, alkylcarbonylamino (in which the amino part is optionally alkyl-substituted), 1- or 2-piperazinyl, piperidyl, piperidino, morpholino, pyrrolidinyl, 1-azetidinyl, carbamoyl, alkylcarbamoyl, dialkylcarbamoyl, (1-piperazinyl)carbonyl, piperidinocarbonyl, (1-pyrrolidinyl)carbonyl, phenyl, pyridyl, 1- imidazolyl, or else R = 2- or 3-pyrrolidinyl or 2-,3- or 4-piperidyl, it being understood that the alkyl radicals form a straight or branched chain and, unless specially mentioned, contain 1 to 10 C and that the piperazinyl, piperidino, piperidyl, pyrrolidinyl and azetidinyl radicals may be unsubstituted or substituted in any position by alkyl, alkylcarbonyl, benzyl or hydroxyalkyl or else may form a lactam functional group with the nitrogen atom of the ring, and, when they exist, their pharmaceutically acceptable salts and the optical isomers of the products of formula (I). <IMAGE> The products of formula (I) are useful as anxiolytics.
NO875012A 1986-12-02 1987-12-01 ANALOGY PROCEDURE FOR THE PREPARATION OF NEW THERAPEUTIC ACTIVE NAFTYRIDINE INGREDIENTS. NO166037C (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8616796A FR2607504B1 (en) 1986-12-02 1986-12-02 NOVEL ISOINDOLINONE DERIVATIVES, THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

Publications (4)

Publication Number Publication Date
NO875012D0 NO875012D0 (en) 1987-12-01
NO875012L NO875012L (en) 1988-06-03
NO166037B NO166037B (en) 1991-02-11
NO166037C true NO166037C (en) 1991-05-22

Family

ID=9341443

Family Applications (1)

Application Number Title Priority Date Filing Date
NO875012A NO166037C (en) 1986-12-02 1987-12-01 ANALOGY PROCEDURE FOR THE PREPARATION OF NEW THERAPEUTIC ACTIVE NAFTYRIDINE INGREDIENTS.

Country Status (23)

Country Link
EP (1) EP0271404B1 (en)
JP (1) JPS63154682A (en)
KR (1) KR880007517A (en)
AT (1) ATE66219T1 (en)
AU (1) AU594215B2 (en)
CA (1) CA1298295C (en)
DE (1) DE3772172D1 (en)
DK (1) DK169969B1 (en)
ES (1) ES2038687T3 (en)
FI (1) FI84723C (en)
FR (1) FR2607504B1 (en)
GR (1) GR3002490T3 (en)
HU (1) HU197573B (en)
IE (1) IE61089B1 (en)
IL (1) IL84658A (en)
MA (1) MA21118A1 (en)
MX (1) MX9558A (en)
NO (1) NO166037C (en)
NZ (1) NZ222752A (en)
OA (1) OA08696A (en)
PT (1) PT86261B (en)
SU (3) SU1616515A3 (en)
ZA (1) ZA879001B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2607506B1 (en) * 1986-12-02 1989-01-06 Rhone Poulenc Sante NOVEL ISOINDOLINONE DERIVATIVES, THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
FR2607503B1 (en) * 1986-12-02 1989-02-24 Rhone Poulenc Sante NOVEL ISOINDOLINONE DERIVATIVES, THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
CZ309617B6 (en) * 2019-04-05 2023-05-24 Ústav organické chemie a biochemie AV ČR, v. v. i 3α5ß-Neuroactive steroids for the treatment of epilepsy and seizure disorders

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2101081B1 (en) * 1970-08-19 1974-01-11 Rhone Poulenc Sa
OA04285A (en) * 1972-01-07 1979-12-31 Rhone Poulenc Sa New derivatives of pyrrolo (3,4-b) pyrazine and their preparation.
AR207555A1 (en) * 1972-12-04 1976-10-15 PROCEDURE TO PREPARE ARIL-6-PIPERAZINOCARBONYLOXY-5 OXO-7-TETRAHYDRO-2,3,6,7 DITIINE (1,4) (2,3-C) PYRROLES
ZA756953B (en) * 1974-11-07 1976-10-27 Rhone Poulenc Ind 1,4-oxathiino(2,3-c)pyrrole derivatives
AR208414A1 (en) * 1974-11-07 1976-12-27 Rhone Poulenc Ind PROCEDURE TO OBTAIN NEW DERIVATIVES OF ((ACIL-4PIPERAZINIL-1) CARBONYLOXI-5 PYRROLINONE-2)
ATE39483T1 (en) * 1982-04-02 1989-01-15 Takeda Chemical Industries Ltd CONDENSED PYRROLINONE DERIVATIVES AND THEIR PREPARATION.
FR2559484B2 (en) * 1983-07-06 1986-09-26 Provesan Sa NEW DERIVATIVE 7- (PYRROL-1-YL) OF 1-ETHYL-1,4-DIHYDRO-4-OXO- (1,8-NAPHTYRIDIN) -3-CARBOXYLIC ACID, ITS PREPARATION AND ITS APPLICATION AS A MEDICAMENT
CS274601B2 (en) * 1983-07-27 1991-09-15 Dainippon Pharmaceutical Co Method of 1,8-naphthyridine derivative production
JPS6169773A (en) * 1984-09-14 1986-04-10 Takeda Chem Ind Ltd Isoindolinone derivative
US4657913A (en) * 1985-04-18 1987-04-14 Warner-Lambert Company Trifluoro- quinoline -3- carboxylic acids and their use as anti-bacterial agents
FR2607506B1 (en) * 1986-12-02 1989-01-06 Rhone Poulenc Sante NOVEL ISOINDOLINONE DERIVATIVES, THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
FR2607503B1 (en) * 1986-12-02 1989-02-24 Rhone Poulenc Sante NOVEL ISOINDOLINONE DERIVATIVES, THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

Also Published As

Publication number Publication date
FI84723C (en) 1992-01-10
DK169969B1 (en) 1995-04-18
IE873252L (en) 1988-06-02
PT86261A (en) 1988-01-01
FI875299A (en) 1988-06-03
HU197573B (en) 1989-04-28
JPS63154682A (en) 1988-06-27
EP0271404A2 (en) 1988-06-15
EP0271404A3 (en) 1989-04-05
IL84658A0 (en) 1988-04-29
NO875012L (en) 1988-06-03
IE61089B1 (en) 1994-09-21
KR880007517A (en) 1988-08-27
EP0271404B1 (en) 1991-08-14
OA08696A (en) 1989-03-31
IL84658A (en) 1992-01-15
DK630487D0 (en) 1987-12-01
ATE66219T1 (en) 1991-08-15
FI84723B (en) 1991-09-30
AU8193687A (en) 1988-06-02
CA1298295C (en) 1992-03-31
PT86261B (en) 1990-11-07
NZ222752A (en) 1989-10-27
SU1616515A3 (en) 1990-12-23
ES2038687T3 (en) 1993-08-01
HUT46007A (en) 1988-09-28
SU1657056A3 (en) 1991-06-15
GR3002490T3 (en) 1992-12-30
NO166037B (en) 1991-02-11
MX9558A (en) 1993-11-01
MA21118A1 (en) 1988-07-01
AU594215B2 (en) 1990-03-01
DK630487A (en) 1988-06-03
DE3772172D1 (en) 1991-09-19
SU1685264A3 (en) 1991-10-15
FR2607504A1 (en) 1988-06-03
FI875299A0 (en) 1987-12-01
NO875012D0 (en) 1987-12-01
ZA879001B (en) 1988-06-01
FR2607504B1 (en) 1989-01-27

Similar Documents

Publication Publication Date Title
NO166036C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF NEW THERAPEUTICALLY ACTIVE NAFTYRIDINE DERIVATIVES.
NO166037C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF NEW THERAPEUTIC ACTIVE NAFTYRIDINE INGREDIENTS.
NO166183C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF NEW THERAPEUTICALLY ACTIVE NAFTYRIDINE DERIVATIVES.